Literature DB >> 4010222

Kinetics of serum creatine kinase and creatine kinase-MB after intracoronary thrombolysis.

F M Bartelsen, W Rehpenning, K Harm, M Runge, D G Mathey.   

Abstract

The kinetics of the activity of total creatine kinase (CK) and creatine phosphokinase isoenzyme muscle-brain were investigated in 48 patients with acute myocardial infarction after successful intracoronary thrombolysis, and compared to the enzyme activities in 17 patients in whom thrombolysis failed. CK activity peaked significantly earlier after a successful thrombolysis than after an unsuccessful attempt: in patients with successful thrombolysis, CKmax = 10.5 +/- 3.7 h and in patients with an unsuccessful attempt, CKmax = 19.3 +/- 5.9 h; p less than or equal to 0.05. The area under the activity time curve after successful thrombolysis was significantly smaller than after unsuccessful thrombolysis: in patients with successful thrombolysis, CK area = 25,255 U/l per day and in patients with an unsuccessful attempt, CK area = 32,602 U/l per day; p = 0.015. There was a negative correlation between the area under the CK serum curve after successful thrombolysis, and the change of regional wall motion at the site of the acute infarct (p less than or equal to 0.05). From the smaller area under the CK curve in patients after successful thrombolysis, and the significant negative correlation of this measurement with regional left ventricular wall motion, we conclude that myocardial salvage after intracoronary thrombolysis can be assessed by serial CK measurements.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4010222     DOI: 10.1007/bf01747979

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  25 in total

1.  The fate of enzymes in body fluids--an experimental study. IV. Relationship of the reticuloendothelial system to activities and disappearance rates of various enzymes.

Authors:  K G WAKIM; G A FLEISHER
Journal:  J Lab Clin Med       Date:  1963-01

2.  Serial CPK determinations for evaluation of size and development of acute myocardial infarction.

Authors:  W H Bleifeld; P Hanrath; D Mathey
Journal:  Circulation       Date:  1976-03       Impact factor: 29.690

3.  [Serial studies on creatine phosphokinase for intravital determination of the extent of the infarct].

Authors:  W Bleifeld; D Mathey; P Hanrath; H Buss; S Effert
Journal:  Verh Dtsch Ges Kreislaufforsch       Date:  1974

4.  [Studies on enzyme disappearance. I. Half-lifes of some cell enzymes in man].

Authors:  U Bär; S Ohlendorf
Journal:  Klin Wochenschr       Date:  1970-07-01

5.  Non surgical coronary artery recanalization in acute transmural myocardial infarction.

Authors:  D G Mathey; K H Kuck; V Tilsner; H J Krebber; W Bleifeld
Journal:  Circulation       Date:  1981-03       Impact factor: 29.690

6.  [Limitation of infarction size by non-surgical recanalization of coronary arteries (author's transl)].

Authors:  K P Rentrop; H Blanke; K R Karsch; G Rahlf; K Leitz
Journal:  Dtsch Med Wochenschr       Date:  1981-06-12       Impact factor: 0.628

7.  Ediortial: Isoenzymes of creatine phosphokinase and diagnosis of myocardial infarction.

Authors:  R Roberts; B E Sobel
Journal:  Ann Intern Med       Date:  1973-11       Impact factor: 25.391

8.  [Activity determination of isoenzyme CK-MB. Application and limitations in the diagnosis of myocardial infarct].

Authors:  D Neumeier; P Sandel; T von Armin; W Prellwitz
Journal:  Verh Dtsch Ges Inn Med       Date:  1977 Apr 17-21

9.  An improved basis for enzymatic estimation of infarct size.

Authors:  R Roberts; P D Henry; B E Sobel
Journal:  Circulation       Date:  1975-11       Impact factor: 29.690

10.  Specificity of elevated serum MB creatine phosphokinase activity in the diagnosis of acute myocardial infarction.

Authors:  R Roberts; K S Gowda; P A Ludbrook; B E Sobel
Journal:  Am J Cardiol       Date:  1975-10-06       Impact factor: 2.778

View more
  3 in total

Review 1.  Intravenous streptokinase. A reappraisal of its therapeutic use in acute myocardial infarction.

Authors:  K L Goa; J M Henwood; J F Stolz; M S Langley; S P Clissold
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

2.  Achievement of coronary artery patency by use of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.

Authors:  W S Hillis; R S Hornung; K J Hogg; N Hockings; J M Burns; F G Dunn
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 3.  Streptokinase. A review of its pharmacology and therapeutic efficacy in acute myocardial infarction in older patients.

Authors:  P E Battershill; P Benfield; K L Goa
Journal:  Drugs Aging       Date:  1994-01       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.